194 related articles for article (PubMed ID: 8289205)
21. Role of NADPH:cytochrome P450 reductase in the hypoxic accumulation and metabolism of BRU59-21, a technetium-99m-nitroimidazole for imaging tumor hypoxia.
Melo T; Ballinger JR; Rauth AM
Biochem Pharmacol; 2000 Sep; 60(5):625-34. PubMed ID: 10927020
[TBL] [Abstract][Full Text] [Related]
22. On the isolation and evaluation of a novel unsubstituted 5-nitroimidazole derivative as an agent to target tumor hypoxia.
Mallia MB; Subramanian S; Mathur A; Sarma HD; Venkatesh M; Banerjee S
Bioorg Med Chem Lett; 2008 Oct; 18(19):5233-7. PubMed ID: 18774708
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological results of the technetium-99m-labeled 4-nitroimidazole for imaging tumor hypoxia.
Chu T; Hu S; Wei B; Wang Y; Liu X; Wang X
Bioorg Med Chem Lett; 2004 Feb; 14(3):747-9. PubMed ID: 14741282
[TBL] [Abstract][Full Text] [Related]
24. Kit formulation for preparation and biological evaluation of a novel (99m)Tc-oxo complex with metronidazole xanthate for imaging tumor hypoxia.
Li Z; Lin X; Zhang J; Wang X; Jin Z; Zhang W; Zhang Y
Nucl Med Biol; 2016 Feb; 43(2):165-70. PubMed ID: 26872441
[TBL] [Abstract][Full Text] [Related]
25. Delineation of the border zone of ischemic rabbit myocardium by a technetium-labeled nitroimidazole.
Di Rocco RJ; Bauer AA; Pirro JP; Kuczynski BL; Belnavis L; Chan YW; Linder KE; Narra RK; Nowotnik DP; Nunn AD
Nucl Med Biol; 1997 Apr; 24(3):201-7. PubMed ID: 9228654
[TBL] [Abstract][Full Text] [Related]
26. Modifying the in vitro accumulation of BMS181321, a technetium-99m-nitroimidazole, with unlabelled nitroaromatics.
Melo T; Hua HA; Ballinger JR; Rauth AM
Biochem Pharmacol; 1997 Sep; 54(6):685-93. PubMed ID: 9310345
[TBL] [Abstract][Full Text] [Related]
27. Technetium-99m N,N'-bis(2-mercapto-2-methylpropyl)-2-aminobenzylamine: technetium-99m complexes of a novel bis(aminoethanethiol) ligand.
Francesconi LC; Yang YY; Kung MP; Zhang XX; Billings JJ; Guo YZ; Kung HF
J Med Chem; 1994 Sep; 37(20):3282-8. PubMed ID: 7932555
[TBL] [Abstract][Full Text] [Related]
28. Oxorhenium(V) and oxotechnetium(V) [NN][S]3 complexes of 2-phenylbenzothiazole derivatives.
Tzanopoulou S; Pirmettis IC; Patsis G; Raptopoulou C; Terzis A; Papadopoulos M; Pelecanou M
Inorg Chem; 2006 Jan; 45(2):902-9. PubMed ID: 16411729
[TBL] [Abstract][Full Text] [Related]
29. Preparation and characterization of [99TcO] apcitide: a technetium labeled peptide.
Francesconi LC; Zheng Y; Bartis J; Blumenstein M; Costello C; De Rosch MA
Inorg Chem; 2004 May; 43(9):2867-75. PubMed ID: 15106974
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and Biological Evaluation of a New Nitroimidazole-99mTc-Complex for Imaging of Hypoxia in Mice Model.
Zhang Q; Zhang Q; Guan Y; Liu S; Chen Q; Li X
Med Sci Monit; 2016 Oct; 22():3778-3791. PubMed ID: 27752036
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of 99mTc(CO)3 complex of 2-methyl-5-nitroimidazole as an agent for targeting tumor hypoxia.
Mallia MB; Subramanian S; Banerjee S; Sarma HD; Venkatesh M
Bioorg Med Chem; 2006 Dec; 14(23):7666-70. PubMed ID: 16949291
[TBL] [Abstract][Full Text] [Related]
32. Kinetic analysis of technetium-99m-labeled nitroimidazole (BMS-181321) as a tracer of myocardial hypoxia.
Ng CK; Sinusas AJ; Zaret BL; Soufer R
Circulation; 1995 Sep; 92(5):1261-8. PubMed ID: 7648674
[TBL] [Abstract][Full Text] [Related]
33. Nitroimidazoles as anaerobic electron acceptors for xanthine oxidase.
Clarke ED; Goulding KH; Wardman P
Biochem Pharmacol; 1982 Oct; 31(20):3237-42. PubMed ID: 6897358
[TBL] [Abstract][Full Text] [Related]
34. Combining bifunctional chelator with (3 + 2)-cycloaddition approaches: synthesis of dual-function technetium complexes.
Braband H; Imstepf S; Benz M; Spingler B; Alberto R
Inorg Chem; 2012 Apr; 51(7):4051-7. PubMed ID: 22416667
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and bioevaluation of radioiodinated nitroimidazole hypoxia imaging agents by one-pot click reaction.
Yang R; Wang D; Chu T
Bioorg Med Chem Lett; 2020 Sep; 30(17):127386. PubMed ID: 32738994
[TBL] [Abstract][Full Text] [Related]
36. ⁹⁹mTc/Re complexes bearing bisnitroimidazole or mononitroimidazole as potential bioreductive markers for tumor: synthesis, physicochemical characterization and biological evaluation.
Mei L; Wang Y; Chu T
Eur J Med Chem; 2012 Dec; 58():50-63. PubMed ID: 23088932
[TBL] [Abstract][Full Text] [Related]
37. Technetium labeling of monoclonal antibodies with functionalized BATOs. 1. TcCl(DMG)3PITC.
Linder KE; Wen MD; Nowotnik DP; Malley MF; Gougoutas JZ; Nunn AD; Eckelman WC
Bioconjug Chem; 1991; 2(3):160-70. PubMed ID: 1932215
[TBL] [Abstract][Full Text] [Related]
38. 99mTcO(BAT-NI), a novel nitroimidazole tracer: in vivo uptake studies in ischaemic myocardium.
Hoffend J; Linke G; Mohammed A; Tiefenbacher CP; Eisenhut M; Haberkorn U
Eur J Nucl Med Mol Imaging; 2003 Apr; 30(4):494-501. PubMed ID: 12574972
[TBL] [Abstract][Full Text] [Related]
39. Photoreduction of 99Tc pertechnetate by nanometer-sized metal oxides: new strategies for formation and sequestration of low-valent technetium.
Burton-Pye BP; Radivojevic I; McGregor D; Mbomekalle IM; Lukens WW; Francesconi LC
J Am Chem Soc; 2011 Nov; 133(46):18802-15. PubMed ID: 21985281
[TBL] [Abstract][Full Text] [Related]
40. Methoxy poly (ethylene glycol)-block-poly (glutamic acid)-graft-6-(2-nitroimidazole) hexyl amine nanoparticles for potential hypoxia-responsive delivery of doxorubicin.
Ahmad Z; Lv S; Tang Z; Shah A; Chen X
J Biomater Sci Polym Ed; 2016; 27(1):40-54. PubMed ID: 26489768
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
